Cargando…
Quality changes to approved biotherapeutic product: Simulated case studies on reporting categories & supporting data requirements
Changes are essential for the continual improvement of the manufacturing process and for maintaining state-of-the-art controls on biotherapeutic products and such changes often need to be implemented after the product has been approved. WHO guidelines on procedures and data requirement for changes t...
Autores principales: | Hamel, Hugo, Kang, Hye-Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863427/ https://www.ncbi.nlm.nih.gov/pubmed/31668453 http://dx.doi.org/10.1016/j.biologicals.2019.10.008 |
Ejemplares similares
-
Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review
por: Bonet Olivencia, Samuel, et al.
Publicado: (2021) -
Editorial: Characterization of biotherapeutic products
por: Rathore, Anurag S., et al.
Publicado: (2022) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023) -
Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins
por: Betterle, Nico, et al.
Publicado: (2020) -
Response regarding Colombian regulation of biotherapeutic products
por: Vaca, Claudia, et al.
Publicado: (2017)